Technologies

Medical Sciences

Title:

AarogyaAI® Rapid Tuberculosis Drug Sensitivity Test

Area:

Medical Sciences

Focus Area:

COPD, Healthcare

Status:

Pilot Study completed

Social Benefits:

There is a dearth of tools in the market that can provide a rapid and comprehensive diagnosis of drug-resistant tuberculosis. Hence, AarogyaAI®’s algorithm is extremely relevant as it provides a comprehensive precision drug susceptibility report for the patients, based on the genome of the M. tb infecting the patient.

Developing Agency:

AarogyaAI Innovations Private Limited:, Bangalore, Karnataka

Technology Readiness Index:

TRL-8

Brief Description

Description :

A combined approach with whole genome sequencing and artificial intelligence, towards combating antimicrobial resistance in tuberculosis, by generating a comprehensive drug susceptibility report for individual patients, a 100X faster than existing solutions.

Related Technologies